GRPEL2 and diabetes mellitus: Our data revealed that diabetes-induced cardiac systolic dysfunction, including decreased LVEF and LVFS as well as increased LVISD, was ameliorated in AAV9-Grpel2-injected diabetic mice (Fig. 1e–i and Additional file 1: Fig. S4A–C).